JSW
TMO icon

Journey Strategic Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Journey Strategic Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
3,807
+390
+11% +$212K 0.05% 110
2025
Q4 		$1.98M Buy
3,417
+12
+0.4% +$6.79K 0.05% 98
2025
Q3 		$1.65M Buy
3,405
+151
+5% +$70.3K 0.05% 111
2025
Q2 		$1.32M Buy
3,254
+1,062
+48% +$444K 0.04% 125
2025
Q1 		$1.09M Buy
2,192
+506
+30% +$274K 0.04% 124
2024
Q4 		$877K Sell
1,686
-299
-15% -$164K 0.03% 139
2024
Q3 		$1.23M Buy
1,985
+292
+17% +$173K 0.05% 108
2024
Q2 		$936K Buy
1,693
+325
+24% +$186K 0.04% 96
2024
Q1 		$795K Sell
1,368
-561
-29% -$315K 0.04% 93
2023
Q4 		$1.02M Buy
1,929
+268
+16% +$130K 0.05% 61
2023
Q3 		$841K Buy
1,661
+223
+16% +$119K 0.04% 68
2023
Q2 		$750K Sell
1,438
-675
-32% -$364K 0.03% 68
2023
Q1 		$1.22M Buy
2,113
+317
+18% +$179K 0.13% 49
2022
Q4 		$989K Buy
1,796
+372
+26% +$197K 0.12% 59
2022
Q3 		$722K Buy
1,424
+551
+63% +$308K 0.1% 51
2022
Q2 		$475K Sell
873
-314
-26% -$173K 0.06% 59
2022
Q1 		$701K Buy
1,187
+61
+5% +$35K 0.08% 33
2021
Q4 		$751K Buy
+1,126
New +$703K 0.08% 50

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Journey Strategic Wealth's TMO Position: Q1 2026 in Review

Journey Strategic Wealth increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, buying an estimated $212K and bringing the position to 3,807 shares worth $1.87M. The position accounts for 0.05% of the portfolio, ranked #110.

Journey Strategic Wealth first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.98M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Journey Strategic Wealth held 3,807 shares of Thermo Fisher Scientific worth $1.87M as of Q1 2026.
  • Journey Strategic Wealth bought 390 Thermo Fisher Scientific shares in Q1 2026, an estimated $212K.
  • Thermo Fisher Scientific made up 0.05% of Journey Strategic Wealth's portfolio in Q1 2026, its #110 holding.
  • Journey Strategic Wealth first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Journey Strategic Wealth's Thermo Fisher Scientific position peaked at $1.98M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.